logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 10 of 10 Items
Showing 1 - 10 of 10 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Letter

Equitable access needed in clinical research

Dang G, Perrin C, Furin J
2025-03-28 • Science
2025-03-28 • Science
Journal Article
|
Commentary

Equitable, personalised medicine for tuberculosis: Treating patients, not diseases

Guglielmetti L, Panda S, Abubakirov A, Salahuddin N, Perrin C,  et al.
2025-03-21 • Lancet Respiratory Medicine
2025-03-21 • Lancet Respiratory Medicine
Journal Article
|
Commentary

Introducing new and repurposed TB drugs: the endTB experience

Seung KJ, Khan UT, Varaine FFV, Ahmed SM, Bastard M,  et al.
2020-10-01 • International Journal of Tuberculosis and Lung Disease
2020-10-01 • International Journal of Tuberculosis and Lung Disease
In 2015, the initiative Expand New Drug Markets for TB (endTB) began, with the objective of reducing barriers to access to the new and repurposed TB drugs. Here we describe the major imp...
Journal Article
|
Pre-Print

MSF Access Campaign drug-resistant tuberculosis research and development case study May 2020

Cox V, Perrin C, Athersuch K, Martin M M, Alsalhani A
2020-06-01 • OSF Preprints
2020-06-01 • OSF Preprints
Two novel drugs, bedaquiline and delamanid, have recently become available to treat drug resistant tuberculosis (DR-TB) after many decades of little innovation in the field of DR-TB trea...
Journal Article
|
Commentary

Access to paediatric formulations for the treatment of childhood tuberculosis

Nash M, Perrin C, Seddon JA, Furin J, Hauser J,  et al.
2020-12-01 • Lancet Child and Adolescent Health
2020-12-01 • Lancet Child and Adolescent Health
Journal Article
|
Commentary

Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study

Perrin C, Athersuch K, Elder G, Martin M, Alsalhani A
2022-04-19 • BMJ Global Health
2022-04-19 • BMJ Global Health
Two drugs with novel mechanisms of action, the diarylquinoline bedaquiline and the nitroimidazole delamanid—as well as pretomanid from the same class of drugs as delamanid—have recently ...
Journal Article
|
Research

Syrian refugees in Greece: experience with violence, mental health status, and access to information during the journey and while in Greece

Ben Farhat J, Blanchet K, Juul Bjertrup P, Veizis A, Perrin C,  et al.
2018-03-13 • BMC Medicine
2018-03-13 • BMC Medicine
BACKGROUND
Since 2015, Europe has been facing an unprecedented arrival of refugees and migrants: more than one million people entered via land and sea routes. During their travels, r...
Journal Article
|
Research

A life in waiting: Refugees' mental health and narratives of social suffering after European Union border closures in March 2016

Bjertrup PJ, Bouhenia M, Mayaud P, Perrin C, Ben Farhat J,  et al.
2019-10-18 • Social Science and Medicine
2019-10-18 • Social Science and Medicine
In 2015, an estimated 856,723 refugees, predominantly from Syria, Afghanistan, and Iraq arrived in Greece as an entry point into the European Union. The border of the Former Yugoslav Rep...
Journal Article
|
Pre-Print

Countries are out of step with international recommendations for tuberculosis testing, treatment, and care: Findings from a 29-country survey of policy adoption and implementation

Saran K, Masini T, Chikwanha I, Paton G, Scourse R,  et al.
2019-02-01 • bioRxiv
2019-02-01 • bioRxiv
BACKGROUND
Tuberculosis (TB) poses a global health crisis requiring robust international and country-level action. Adopting and implementing TB policies from the World Health Organiz...
Journal Article
|
Commentary

Access to essential medicines to treat chronic respiratory disease in low-income countries

Bissell K, Perrin C, Beran D
2016-06-01 • International Journal of Tuberculosis and Lung Disease
2016-06-01 • International Journal of Tuberculosis and Lung Disease
Chronic respiratory diseases (CRDs) affect hundreds of millions of people. The United Nations 2011 meeting on non-communicable diseases (NCDs) marked a turning point in addressing this b...